Human chorionic gonadotropin modulates prostate cancer cell survival after irradiation or HMG CoA reductase inhibitor treatment.
Molecular pharmacology (2006) - Comments
doi: 10.1124/mol.106.031153  pubmed: 17050804  issn: 0026-895X  pii: mol.106.031153 

Adly Yacoub, William Hawkins, David Hanna, Hong Young, Margaret A Park, Mark Grant, John D Roberts, David T Curiel, Paul B Fisher, Kristoffer Valerie, Steven Grant, Michael P Hagan, Paul Dent